Literature DB >> 14803634

Studies on immunity in anthrax. I. Variation in the serum T-agglutinin during anthrax infection in the rabbit.

G G WRIGHT, J B SLEIN.   

Abstract

An abrupt decrease in the titer of serum T-agglutinin frequently occurs during the acute phase of anthrax infection in the rabbit. In partially immunized animals which survive the infection the titer returns to normal during convalescence, but has not been observed to rise significantly above the normal level. The presence of a substance capable of inhibiting T-agglutination may be demonstrated in the sera of many of those animals in which a marked decrease in T-agglutinin has occurred. The polysaccharide and polypeptide antigens of B. anthracis do not possess this activity. Sera containing the T-inhibitory substance usually produce a slow hemolysis of T-erythrocytes and also of normal human type O erythrocytes; hemolysis of erythrocytes of other species is irregular. This reactivity of the sera withstands inactivation at 56 degrees C. but is inhibited by citrate. T-inhibitory and hemolytic activities can frequently be increased by incubation of the acute-phase serum at 37 degrees C. The ability of normal serum to neutralize the T-inhibitory and hemolytic activities of acute-phase serum is not significantly increased after recovery from the infection. The meaning of the results is discussed.

Entities:  

Keywords:  ANTHRAX

Mesh:

Substances:

Year:  1951        PMID: 14803634      PMCID: PMC2136058          DOI: 10.1084/jem.93.2.99

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  The capsular substance of Bacillus anthracis: With an appendix by P. Bruce White.

Authors:  W E Hanby; H N Rydon
Journal:  Biochem J       Date:  1946       Impact factor: 3.857

  1 in total
  3 in total

1.  Studies on immunity in anthrax. IV. Factors influencing elaboration of the protective antigen of bacillus antracis in chemically defined media.

Authors:  M PUZISS; G G WRIGHT
Journal:  J Bacteriol       Date:  1954-10       Impact factor: 3.490

2.  Field Evaluation of a Human Anthrax Vaccine.

Authors:  P S Brachman; H Gold; S A Plotkin; F R Fekety; M Werrin; N R Ingraham
Journal:  Am J Public Health Nations Health       Date:  1962-04

Review 3.  Anthrax vaccination strategies.

Authors:  Robert J Cybulski; Patrick Sanz; Alison D O'Brien
Journal:  Mol Aspects Med       Date:  2009-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.